13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13G Filed 2026-07-27 Event — SEC 0001716774-26-000020 →

Aberdeen Group plc Eloxx Pharmaceuticals Inc ELOX

Stake: Shares: Class: Common Stock, $0.01 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
2 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
9 13D/G filings on this issuer
8 other filings besides this one
Filer Track Record
3 filings by this filer
2 other filings in the data moat
Short Interest · settle 2026-07-15
DTC 1.00
10,987 shares short · +41.8% vs prior

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-05-27 Coastlands Capital LP 10%+ owner J 1,250,000
2026-05-27 Coastlands Capital LP 10%+ owner J 1,250,000 $0.01 $13K

Other 13D/G Filings on Eloxx Pharmaceuticals Inc

FiledFormFilerStakeShares
2026-06-17 SCHEDULE 13G Coastlands Capital LP view →
2026-06-17 SCHEDULE 13G Domicilium Real Estate Fund III LP view →
2026-06-16 SCHEDULE 13G Stonepine Capital Management, LLC view →
2026-06-16 SCHEDULE 13G EcoR1 Capital, LLC view →
2026-06-15 SCHEDULE 13G Invus Global Management, LLC view →
2022-02-03 SC LSP V Cooperatieve U.A. view →
2021-05-21 SC Pontifax Management III G.P. (2011) Ltd. view →
2019-06-26 SC Pontifax Management III G.P. (2011) Ltd. view →

Other Filings by Aberdeen Group plc

FiledFormIssuerStakeShares
2026-07-20 SCHEDULE 13G/A CODEXIS, INC. view →
2026-07-20 SCHEDULE 13G/A uniQure N.V. view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →